Spotlight paper in World Journal of Hepatology: Alshaima Al Hinai
Recognition for former RI-MUHC trainee’s work on nonalcoholic fatty liver disease
COVID-19: A close look at vaccine strategies used with older people in Quebec
A new study determines the maximum recommended interval between the first and second doses of mRNA...
CTN study tests new drug for the first time in people living with HIV
Postdoc Léna Royston aims to understand how cytomegalovirus infection can increase inflammation and cause health issues
Fall 2021 CIHR competition results
RI-MUHC teams received $9.5 million in project funding
Marcel Behr appointed interim director McGill Interdisciplinary Initiative in Infection and Immunity
Founding director Don Sheppard to direct Antimicrobial Resistance Task Force at the Public Health Agency...
A clear picture of the cost and efficacy of COVID-19 outpatient treatments
In a new study, RI-MUHC researchers have assessed all available outpatient therapies for COVID-19 to facilitate...
Three RI-MUHC research projects funded in special CIHR calls
Projects will mitigate impacts of the COVID-19 pandemic on children, youth and families and promote vaccine confidence
Multiplexed technologies are paving the way to rapid and equitable screening for sexually transmitted infections
Work by RI-MUHC postdoc Angela Karellis published in The Lancet...
Can inhaled corticosteroids alleviate early symptoms of COVID-19?
Results from the CONTAIN study conducted at the RI-MUHC reveal that ciclesonide is no better than placebo
RI-MUHC team detects impact of HIV antiretroviral therapy on the anti-tuberculosis immune response
Alveolar macrophages, cells important for protection from tuberculosis infection, are adversely impacted by...